INTECH INVESTMENT MANAGEMENT LLC
Position in ADCT — ADC Therapeutics SA
CIK 1086318
WEST PALM BEACH, FL
Position in ADCT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$89,955
-$40,443 QoQ
Shares Held
23,988
-35.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026INTECH INVESTMENT MANAGEMENT LLC holds $94,314,635 across 29 Drug Manufacturers - Specialty & Generic names. ADCT ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
311,871 | $36,866,270 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
478,939 | $14,425,641 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
20,744 | $12,300,776 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
86,315 | $11,371,137 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
44,826 | $3,400,052 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
88,945 | $2,711,043 | |
| 7 | ALKS |
Alkermes plc.
|
60,967 | $2,155,793 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
38,984 | $2,015,082 |
All Filings in ADCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $89,955 | 23,988 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $130,398 | 36,940 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $144,724 | 36,181 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $96,965 | 36,181 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $88,649 | 62,872 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $76,485 | 38,435 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $40,943 | 12,998 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||